FAQ

PNU 159682

Known as: 3'-deamino-3'',4'-anhydro-(2''(S)-methoxy-3''(R)-oxy-4''-morpholinyl)doxorubicin, PNU-159682 
 

Topic mentions per year

Topic mentions per year

2005-2017
01220052017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Modulating Antibody-Drug Conjugate Payload Metabolism by Conjugation Site and Linker Modification.
Previous investigations on antibody-drug conjugate (ADC) stability have focused on drug release by linker-deconjugation due to… (More)
Is this relevant?
2017
2017
Virtual Cross-Linking of the Active Nemorubicin Metabolite PNU-159682 to Double-Stranded DNA.
The DNA alkylating mechanism of PNU-159682 (PNU), a highly potent metabolite of the anthracycline nemorubicin, was investigated… (More)
Is this relevant?
2017
2017
Highly Potent, Anthracycline-based Antibody-Drug Conjugates Generated by Enzymatic, Site-specific Conjugation.
Antibody-drug conjugates (ADC) are highly potent and specific antitumor drugs, combining the specific targeting of mAbs with the… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2016
2016
Acetazolamide Serves as Selective Delivery Vehicle for Dipeptide-Linked Drugs to Renal Cell Carcinoma.
In most cases, cytotoxic drugs do not preferentially accumulate at the tumor site, causing unwanted toxicities and preventing… (More)
Is this relevant?
2015
2015
A Novel Anti-CD22 Anthracycline-Based Antibody-Drug Conjugate (ADC) That Overcomes Resistance to Auristatin-Based ADCs.
PURPOSE We are interested in identifying mechanisms of resistance to the current generation of antibody-drug conjugates (ADC) and… (More)
  • table 1
  • table 2
Is this relevant?
2012
2012
The interaction of nemorubicin metabolite PNU-159682 with DNA fragments d(CGTACG)(2), d(CGATCG)(2) and d(CGCGCG)(2) shows a strong but reversible binding to G:C base pairs.
The antitumor anthracycline nemorubicin is converted by human liver microsomes to a major metabolite, PNU-159682 (PNU), which was… (More)
Is this relevant?
2008
2008
In vitro hepatic conversion of the anticancer agent nemorubicin to its active metabolite PNU-159682 in mice, rats and dogs: a comparison with human liver microsomes.
We recently demonstrated that nemorubicin (MMDX), an investigational antitumor drug, is converted to an active metabolite, PNU… (More)
Is this relevant?
2005
2005
Formation and antitumor activity of PNU-159682, a major metabolite of nemorubicin in human liver microsomes.
PURPOSE Nemorubicin (3'-deamino-3'-[2''(S)-methoxy-4''-morpholinyl]doxorubicin; MMDX) is an investigational drug currently in… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?